In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
The Lancet Infectious Diseases in conversation with
00:00
Why Platform Trials Grew During COVID-19
Saleha asks why adaptive platforms gained popularity; Steven and Josh explain scalability, rapid answers during pandemics, and caution against overuse.
Play episode from 08:24
Transcript
